Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LingQiShen (灵芪参口服液) is a traditional Chinese medicine oral liquid formulation used primarily for supplementing the liver and kidney, benefiting the spleen and lung, generating body fluids and blood. It is indicated for conditions such as spleen deficiency with poor appetite, lung deficiency with cough and asthma, blood deficiency with sallow complexion, general fatigue due to qi deficiency, soreness of waist and knees, cold uterus (宫冷), neurasthenia (神经衰弱), dizziness and insomnia (头昏失眠), chronic bronchitis (慢性支气管炎), and coronary heart disease (冠心病)[1]. The mechanism of action is based on traditional Chinese medicine theory—tonifying qi and blood as well as nourishing yin—which may involve immunomodulatory effects or improvement in microcirculation according to modern pharmacological interpretations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lingqishen.